4/A
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-034265
General Counsel sold 553 shares at $9.36 ($5,176)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Edward General Counsel | 2022-10-20 | Sale | −553 | $9.36 | $5,176 | 249,377 | D: show line 1 in the form |
| Open-market sales · 553 sh · avg $9.36 · $5,176 | |||||||
Loading xslF345X03/doc4a.xml…